Skip to main content

Hypertonie

  • Conference paper
  • 27 Accesses

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 87))

Zusammenfassung

Seit dem Nachweis der blutdrucksenkenden Wirksamkeit von Propranolol sind zahlreiche ß- Rezeptorenblocker in die Therapie eingeführt worden, die sich aufgrund ihrer pharmakologischen Eigenschaften zum Teil deutlich voneinander unterscheiden.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Franz I-W, Lohmann FW (1978) Die Bedeutung der ergometrischen Untersuchung zur Beurteilung der antihypertensiven Therapie. Dtsch Med Wochenschr 38: 1478

    Google Scholar 

  2. Franz I-W (1980) Differential antihypertensive effect of acebutolol and the fixed combination hydrochlorothiazide/amiloridehydrochloride on elevated exercise blood pressures in hypertensive patients. Am J Cardiol 46: 301

    PubMed  CAS  Google Scholar 

  3. Franz I-W (1980) Die antihypertensive Wirksamkeit einer fixen ß-Rezeptorenblocker-Diuretikum-Kombination auf Ruhe-und Belastungsblutdruck von essentiellen Hypertonikern. Schweiz Med Wochenschr 110: 1616

    PubMed  CAS  Google Scholar 

  4. Harry JD, Knapp MF, Linden RJ, Stoker JB, Newcombe C (1979) Effects of 4 ß-adrenoreceptor blocking drugs on blood pressure and exercise heart rate in hypertension. Eur J Cardiol 10: 131

    PubMed  CAS  Google Scholar 

  5. Harry JD, Cruickshank JM, Young J (1979) Once-daily beta blockers and blood-pressure response to exercise. Lancet 8: 250

    Google Scholar 

  6. Watson RDS, Stallard T, Littler WA (1979) Influence of once-daily administration of ß-adrenoreceptor antagonists on arterial pressure and its variability. Lancet 6: 1210

    Google Scholar 

  7. Bobik A, Jennings GL, Korner PI, Ashley P, Jackman G (1979) Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Br J Clin Pharmacol 7: 545–549

    PubMed  CAS  Google Scholar 

  8. Brunner L, Imhof P, Jack D (1975) Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man. Eur J Clin Pharmacol 8: 3–9

    PubMed  CAS  Google Scholar 

  9. Regardh C-G, Johnsson G, Jordö L, Sölvell L (1975) Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow release tablets in single and multiple doses. Acta Pharmacol Toxicol (Kbh) (Suppl V ) 36: 45–58

    CAS  Google Scholar 

  10. Taylor SH, Thadani U, Watt SJ, Goldstraw PW, Hess H, Riess W (1977) Studies with slow release oxprenolol II: acute and chronic administration to patients with exercise-induced angina pectoris. In: Judd L (ed) Topics in cardiovascular disease. An international symposium, Basle, 7th-9th May 1976. CIBA laboratories, Horsham, England, p 131

    Google Scholar 

  11. Watson RDS, Littler WA (1979) Onset and duration of ß-adrenergic receptor blockade following single oral dose acebutolol hydrochloride ( Sectral ). Br J Clin Pharmacol 7: 557–561

    Google Scholar 

  12. Bahlmann J, Brod J, Hubrich W, Pretschner P (1980) Beeinflussung der hämodynamischen Streßreaktion bei Hypertonikern durch eine kombinierte alpha-und beta-Blockade mit Labetalol. Dtsch Med Wochenschr 41: 1414–1418

    Google Scholar 

  13. Beilin JL, Juel-Jensen BE (1972) Alpha-and beta-adrenoceptor blockade in hypertension. Lancet 1: 972–982

    Google Scholar 

  14. Johnson FO, La Brooy J, Munro-Faure AD (1976) Comparative anti-hypertensive effects of Labetalol and the combination of Oxyprenolol and Pentolamine. Br J Clin Pharmacol (Suppl) 3: 783–787

    CAS  Google Scholar 

  15. Koch G (1977) Acute hemodynamic effects of an alpha-and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am Heart J 93: 581–585

    Google Scholar 

  16. Lund-Johansen P, Bakke OM (1979) Hemodynamic effects and plasma concentrations of Labetalol during long-term treatment of essential hypertension. Br J Clin Pharmacol 7: 169–174

    PubMed  CAS  Google Scholar 

  17. Mörl H (1976) Quantitative Meßmethoden der peripheren Durchblutung. Medizinische Technik 96: 87–91

    Google Scholar 

  18. Pugsley DJ, Armstrong BK, Nassim MA, Beilin JL (1976) Controlled comparison of Labetalol and Propanolol in the management of severe hypertension. Br J Clin Pharmacol (Suppl 3 ) 4: 777–782

    CAS  Google Scholar 

  19. Richards DA, Prichard BNC (1979) Clinical pharmacology of Labetalol. Br J Pharmacol (Suppl 2 ) 8: 895–935

    Google Scholar 

  20. Simpson FO (1974) Beta-adrenoceptor-blocking drugs in hypertension. Drugs 7: 85–105

    PubMed  CAS  Google Scholar 

  21. Blakeley AGH, Summers JR (1977) The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen. Br J Pharmacol 59: 643–650

    PubMed  CAS  Google Scholar 

  22. Brittain RT, Levy GP (1976) A review of the animal pharmacology of labetalol, a combined alpha-and beta-adrenoceptor-blocking drug. Br J Clin Pharmacol (Suppl) 681–694

    Google Scholar 

  23. Brodgen RN, Heel RC, Speight TM, Avery GS (1978) Labetalol: A review of its pharmacology and therapeutic use in hypertension. Drugs 15: 251–270

    Google Scholar 

  24. Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19: 1161–1174

    PubMed  Google Scholar 

  25. Kennedy I, Levy GP (1975) Combined alpha-and beta-adrenoceptor blocking drug AH 5158: Further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol 53: 585–592

    Google Scholar 

  26. Langer SZ, Massingham R, Shepperson NB (1980) Presence of postsynaptic alpha2-adrenoceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb. Clin Sci 59: 225s - 228s

    PubMed  CAS  Google Scholar 

  27. Levy GP, Richards DA (1980) Labetalol. In: Scriabine A (ed) Pharmacology of antihypertensive drugs. Raven Press, New York, p 325

    Google Scholar 

  28. Mehta J, Cohn JN (1977) Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects. Circulation 55: 370–375

    PubMed  CAS  Google Scholar 

  29. Richards DA, Tuckman J, Prichard BNC (1976) Assessment of alpha-and beta-adrenoceptor blocking actions of labetalol. Br J Clin Pharmacol 3: 849–855

    PubMed  CAS  Google Scholar 

  30. Richards DA, Prichard BNC, Boakes AJ, Tuckman J, Knight EJ (1977) Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J 1: 99–106

    CAS  Google Scholar 

  31. Richards DA, Prichard BNC (1978) Concurrent antagonism of isoproterenol and norepinephrine after labetalol. Clin Pharmacol Ther 23: 253–258

    PubMed  CAS  Google Scholar 

  32. Richards DA, Prichard BNC, Hernandez R (1979) Circulatory effects of noradrenaline and adrenaline before and after labetalol. Br J Clin Pharmacol 7: 371–378

    PubMed  CAS  Google Scholar 

  33. Hoel BL et al. (1970) Hemodynamic responses to sustained handgrip in patients with hypertension. Acta Med Scand 188: 491–495

    PubMed  CAS  Google Scholar 

  34. Nyberg G (1976) Blood pressure and heart rate responses to isometric exercise and mental arithmetic in normotensive and hypertensive subjects. Clin Sci Mol Med 51: 681–685

    Google Scholar 

  35. Sannerstedt R, Julius S (1972) Systemic hemodynamics in borderline arterial hypertension: responses to static exercise before and under the influence of propranolol. Cardiovasc Res 6: 398–403

    PubMed  CAS  Google Scholar 

  36. Kozlowski S et al. (1973) Plasma catecholamines during sustained isometric exercise. Clin Sci Mol Med 45: 723–731

    PubMed  CAS  Google Scholar 

  37. Lake CR et al. (1977) Lack of correlation of plasma norepinephrine and dopamine-beta-hydroxylase in hypertensive and normotensive subjects. Circ Res 41: 865–869

    PubMed  CAS  Google Scholar 

  38. Martin CE et al. (1974) Autonomic mechanisms in hemodynamic responses to isometric exercise. J Clin Invest 54: 104–115

    PubMed  CAS  Google Scholar 

  39. McAllister RG (1979) Effect of adrenergic receptor blockade on the responses to isometric handgrip: studies in normal and hypertensive subjects. J Cardiovasc Pharmacol 1: 253–263

    PubMed  CAS  Google Scholar 

  40. Brittain RT, Levy GP (1976) A review of the animal pharmacology of labetalol, a combined alpha-and beta-adrenoreceptor blocking drug. Br J Clin Pharmacol 3: 681–694

    PubMed  CAS  Google Scholar 

  41. Weidmann P et al. (1978) Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Am J Cardiol 41: 570–576

    PubMed  CAS  Google Scholar 

  42. Peuler JD, Johnson GA (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21: 625–636

    PubMed  CAS  Google Scholar 

  43. Haber E et al (1969) Application or radioimmunoassay for angiotensin Ito the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349–1354

    PubMed  CAS  Google Scholar 

  44. DeQuattro V, Chan S (1973) Raised plasma catecholamines in some patients with primary hypertension. Lancet 1: 806–809

    Google Scholar 

  45. Robertson D et al. (1979) Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension. Hypertension 1: 118–124

    PubMed  CAS  Google Scholar 

  46. Rand MJ et al. (1975) Inhibitory feedback modulation of adrenergic transmission. Clin Exp Pharmacol Physiol 2: 21–26

    PubMed  CAS  Google Scholar 

  47. Filinger EJ et al. (1978) Evidence for the presynaptic location of the alpha-adrenoceptors which regulate noradrenaline release in the rat submaxillary gland. Naunyn-Schmiedebergs Arch Pharmacol 304: 21–26

    PubMed  CAS  Google Scholar 

  48. Distler A (1980) Pathobiochemie der essentiellen Hypertonie. Verh Dtsch Ges Inn Med 86: 295–303

    PubMed  CAS  Google Scholar 

  49. Hollenberg NK, Solomon HS, Adams DF, Abrams RL, Merrill JP (1972) Renal vascular responses to angiotensin and norepinephrine in normal man. Circ Res 31: 750–757

    PubMed  CAS  Google Scholar 

  50. Lake CR, Ziegler MG, Coleman MD, Kopin IJ (1977) Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208–233

    PubMed  CAS  Google Scholar 

  51. Lehmann M, Keul J, Dickhuth HH, Korsten-Reck U (1981) Plasmacatecholamine und Hämodynamik in Ruhe und während Belastung beim primären Hochdruck. Herz/Kreislauf 13: 11–18

    Google Scholar 

  52. Lehmann M, Keul J, Huber G, Bachl N, Simon G (1981) Alters-und belastungsbedingtes Verhalten der Plasmacatecholamine. Klin Wochenschr 59: 19–25

    PubMed  CAS  Google Scholar 

  53. Lehmann M, Keul J, Löllgen H, Just H (1981) Plasmacatecholamine und Hämodynamik bei gestörter linksventrikulärer Funktion in Ruhe und während Belastung. Z Kardiol 70: 238–244

    PubMed  CAS  Google Scholar 

  54. Lehmann M, Keul J, Huber G, Da Prada M (1981) Plasma catecholamines in trained and untrained volunteers during graduated exercise. Int J Sports Med (in press)

    Google Scholar 

  55. Lehmann M, Keul J (1981) Zum Verhalten der Plasmacatecholamine und der Hämodynamik bei congestiver Cardiomyopathie (im Druck)

    Google Scholar 

  56. Philipp T, Distler A, Cordes U (1978) Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet 2: 959–963

    PubMed  CAS  Google Scholar 

  57. Roskamm H, Reindell H (1977) Versuch einer klinischen Stadieneinteilung. In: Reindell H, Roskamm H (Hrsg) Herzkrankheiten. Springer, Heidelberg, S 383–387

    Google Scholar 

  58. Bravo EL, Tarazi RC, Gifford RW, Steward BH (1979) Circulating and urinary catecholamines in pheochromocytoma. N Engl J Med 301: 682

    PubMed  CAS  Google Scholar 

  59. Christensen NJ (1972) Increased levels of plasma noradrenaline in hypothyroidism. J Clin Endocrinol 35: 359

    CAS  Google Scholar 

  60. Cordes U, Keller H, Beyer J (1975)

    Google Scholar 

  61. Der diagnostische Wert der Plasmakatecholaminbestimmung bei primärer Nebennierenrindeninsuffizienz. Verh Dtsch Ges Inn Med 81: 1540

    Google Scholar 

  62. Cordes U, Georgi M, Günther R, Beyer J (1979) Adrenale und extraadrenale Phäochromocytome. Dtsch Med Wochenschr 104: 317

    PubMed  CAS  Google Scholar 

  63. Cordes U, Beyer J (1981) Diagnostik des Phäochromocytoms. Med Klin 76: 242

    PubMed  CAS  Google Scholar 

  64. Kaiser G, Wiemer G, Dietz J, Hellrich M, Palm D (1976) Characterisation by ligand-bindings of ß-adrenergic receptors in membranes from red blood cells from rats. Naunym-Schmiedebergers Arch Pharmacol (Suppl R) 5: 293

    Google Scholar 

  65. Lehmann M, Keul J (1981) Plasmakatecholamine und Hämodynamik in Ruhe und während Belastung beim primären Hochdruck. Verh Dtsch Ges Inn Med 87 (im Druck)

    Google Scholar 

  66. Louis WJ, Doyle AE, Anavekar SN (1975) Plasma noradrenaline concentration and blood pressure in essential hypertension, pheochromocytoma and depression. Clin Sci Mol Med 48: 239

    Google Scholar 

  67. Pedersen EB, Christensen NJ (1975) Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand 198: 373

    PubMed  CAS  Google Scholar 

  68. Renzini V, Brunori CA, Valori C (1970) A sensitive and specific fluorometric method for the determination of noradrenalin and adrenalin in plasma. Clin Chim Acta 30: 587

    PubMed  CAS  Google Scholar 

  69. Stakpole RH, Melicow MM, Uson AC (1963) Pheochromocytoma in children. J Pediatr 63: 315 1

    Google Scholar 

  70. Miura Y, Campese V, Quatro V de, Meijer D (1977) Plasma catecholamines via an improved fluorimetric assay: comparison with an enzymatic method. J Lab Clin Med 89: 421

    PubMed  CAS  Google Scholar 

  71. Bramley TA, Coleman R, Finean JB (1971) Chemical, enzymological and permeability properties of human erythrocyte ghosts prepared by hypotonic lysis in media of different osmolarities. Biochim Biophys Acta 241: 752–768

    PubMed  CAS  Google Scholar 

  72. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302: 772–776

    PubMed  CAS  Google Scholar 

  73. Edmondson RPS, Thomas RD, Hilton PJ, Patrick J, Jones NF (1975) Abnormal leucocyte composition and sodium transport in essential hypertension. Lancet 1: 1003–1005

    PubMed  CAS  Google Scholar 

  74. Fadeke Aderounmu A, Salako LA (1979) Abnormal cation composition and transport in erythrocytes from hypertensive patients. Eur J Clin Invest 9: 369–375

    Google Scholar 

  75. Garay RP, Elghozi JL, Dagher G, Meyer P (1980) Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes. N Engl J Med 302: 769–771

    PubMed  CAS  Google Scholar 

  76. Garay RP, Meyer P (1979) A new test showing abnormal net Na’ and K+ fluxes in erythrocytes of essential hypertensive patients. Lancet 1: 349–353

    PubMed  CAS  Google Scholar 

  77. Lang S, Blaustein MP (1980) The role of the sodium pump in the control of vascular tone in the rat. Circ Res 46: 463–470

    PubMed  CAS  Google Scholar 

  78. Losse H, Wehmeyer H, Wessels F (1960) Der Wasser-und Elektrolytgehalt von Erythrozyten bei arterieller Hypertonie. Klin Wochenschr 38: 393–395

    PubMed  CAS  Google Scholar 

  79. Postnov YV, Orlov SN, Shevchenko A, Adler A (1977) Altered sodium binding and Na-K-ATPase activity in the red cell membrane in essential hypertension. Pfluegers Arch 371: 263–269

    CAS  Google Scholar 

  80. Rosenthal AS, Kregenow FM, Moses HL (1970) Some characteristics of a Cat+dependent ATPase activity associated with a group of erythrocyte membrane proteins which form fibrils. Biochim Biophys Acta 196: 254–262

    PubMed  CAS  Google Scholar 

  81. Schrier SL, Godin D, Gould RG, Swyryd B, Junga I, Seeger M (1971) Characterization of microvesicles produced by shearing of human erythrocyte membranes. Biochim Biophys Acta 233: 26–36

    PubMed  CAS  Google Scholar 

  82. Walter U, Distler A (1980) Effects of ouabain and furosemide on ATPase activity and sodium transport in erythrocytes of normotensives and of patients with essential hypertension. In: Zumkley H, Losse H (eds) Intracellular electrolytes and arterial hypertension. Thieme, Stuttgart, pp 170–181

    Google Scholar 

  83. Wambach G, Helber A, Bönner G, Hummerich W (1978) Natrium-Kalium-ATPase-Aktivität in Erythrozytenghost und Elektrolytkonzentrationen in Erythrozyten von Patienten mit essentieller Hypertonie. Verh Dtsch Ges Inn Med 84: 800–803

    PubMed  Google Scholar 

  84. Wessels F (1980) Genetic aspects of sodium metabolism in RBC. In: Zumkley H, Losse H (eds) Intracellular electrolytes and arterial hypertension. Thieme, Stuttgart, pp 221–227

    Google Scholar 

  85. Engelman K, Portnoy B (1970) Circ Res 26: 53

    PubMed  CAS  Google Scholar 

  86. De Quattro V, Chan S (1972) Lancet 1: 806

    Google Scholar 

  87. Pedersen EB, Christensen NJ (1975) Acta Med Scand 198: 373

    PubMed  CAS  Google Scholar 

  88. Lake CR, Ziegler MG, Coleman MD, Kopin IJ (1977) N Engl J Med 296: 208

    PubMed  CAS  Google Scholar 

  89. Henquet JW, Kho T, Schols M, Thijssen H, Rahn KH (1981) Clin Sci 60: 25

    PubMed  CAS  Google Scholar 

  90. Robinson BF, Epstein SE, Beiser GD, Braunwald E (1966) Circ Res 19: 400

    PubMed  CAS  Google Scholar 

  91. Dollery CT, Davies DS, Draffan GM, Dargie HJ, Dean CR, Reid JL, Clare RA, Murray S (1976) Clin Pharmacol Ther 19: 111

    Google Scholar 

  92. Eiff AW v, Czernik A, Horbach H, Jörgens H, Wenig HG (1974) DFG-Forschungsbericht Fluglärmwirkungen. Der medizinische Untersuchungsteil, Bd I. Bold, Boppard, S 349–424

    Google Scholar 

  93. Eiff AW v, Neus H (1980) Verkehrslärm und Hypertonie-Risiko, 1. Mitteilung. Munch Med Wochenschr 122: 894–896

    Google Scholar 

  94. Eiff AW v, Friedrich G, Langewitz W, Neus H, Rüddel H, Schirmer G, Schulte W (1981) Verkehrslärm und Hypertonie-Risiko. Hypothalamus-Theorie der essentiellen Hypertonie. 2. Mitteilung. Mönch Med Wochenschr 123: 420–424

    Google Scholar 

  95. Noffke HU (1977) Messung und Analyse vegetativer Stressreaktionen. Diss. Nat. wiss. Fak., Bonn

    Google Scholar 

  96. Eiff AW v, Blumenberg FE, Neus H, Noffke HU, Schirmer G (1980) Ein flexibles Meßwerterfassungssystem und seine Anwendung bei der Analyse vegetativer Reaktionen. EDV in Medizin und Biologie 11: 40–43

    Google Scholar 

  97. Eiff AW v (Hrsg) (1967) Essentielle Hypertonie. Thieme, Stuttgart (jap. Ausgabe 1971 )

    Google Scholar 

  98. Eiff AW v (1964) Funktionsspezifische Effekte und Gewöhnungsphänomene bei Lärm unterschiedlicher Zeitstruktur. In: Psychologische Fragen der Lärmforschung. Kolloquium Berlin, Steglitz. DFG, Bonn-Bad Godesberg, S 109–118

    Google Scholar 

  99. Prichard BNC (1964) Hypotensive action of pronethalol. Br Med J 1: 1227

    PubMed  CAS  Google Scholar 

  100. Eiff AW v (1965) Der Gewöhnungseffekt in der therapeutisch-klinischen Forschung. III. Conferentia Hungarica pro therapia et investigatione in pharmacologia, Budapest, S 127–131

    Google Scholar 

  101. Eiff AW v, Czernik A, Zanders K (1969) Zur medikamentösen Beeinflussung der Sympathikushyperaktivität. Parasympathomimetikum und Betarezeptorenblocker im kurzdauernden pharmakologischen Experiment am Menschen. Klin Wochenschr 47: 701–708

    Google Scholar 

  102. Wright BM, Dore CF (1970) A Random-Zero-Sphygmomanometer. Lancet 1: 337–338

    PubMed  CAS  Google Scholar 

  103. Neus H, Eiff AW v, Friedrich G, Heusch G, Schulte W (1981) Das Problem der Adaptation in der klinisch-therapeutischen Hypertonieforschung. Dtsch Med Wochenschr 106 (im Druck)

    Google Scholar 

  104. Eiff AW v, Neus H, Schulte W (1978) Streßreagibilität als Charakteristikum von Blutdruckgruppen. Verh Dtsch Ges Inn Med 84: 792–795

    Google Scholar 

  105. Schulte W, Neus H (1979) Bedeutung von Streßreaktionen in der Hypertoniediagnostik. Herz/Kreislauf 11: 541–546

    Google Scholar 

  106. Kisch ES, Dluhy RG, Williams GH (1976) Enhanced aldosterone response to angiotensin II in human hypertension. Circ Res 38: 502–505

    PubMed  CAS  Google Scholar 

  107. Williams GH, Dluhy RG, Moore TJ (1977) Aldosterone regulation in essential hypertension. Mayo Clin Proc 52: 312–316

    PubMed  CAS  Google Scholar 

  108. Wisgerhof M, Brown RD (1977) Increased adrenal sensitivity to angiotensin II in Low renin essential hypertension. J Clin Invest 78: 1456–1462

    Google Scholar 

  109. Haber E, Koerrer T, Page LB, Liman B, Purnode A (1969) Application of radioimmunoassay for angiotensin Ito the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349–1356

    PubMed  CAS  Google Scholar 

  110. Witzgall H, Hassan-Ali S (1980) Paper chromatographic systems for the preparation of aldosterone 18-OH-corticosterone, 18-OH-deoxy-corticosterone, corticosterone and deoxycorticosterone. J Chromatogr 198: 70–75

    PubMed  CAS  Google Scholar 

  111. Witzgall H, Hassan-Ali S (1981) A simultaneous radioimmunoassay for aldosterone and its precursors. Human plasma levels following converting-enzyme inhibition before and after blockade of prostaglandin biosynthesis. J Clin Chem Clin Biochem (in press)

    Google Scholar 

  112. Weber PC, Larsson C, Änggard E, Hamberg M, Corey EJ, Nicolaou KG, Samuelsson B (1976) Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin peroxides. Circ Res 39: 868–874

    CAS  Google Scholar 

  113. Witzgall H (1980) Unveröffentlichte Befunde

    Google Scholar 

  114. Semple PF, Mason PA, Fraser R (1980) Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension. Clin Endocrinol (Oxf) 12: 473–481

    CAS  Google Scholar 

  115. Fraser R, Lantos CP (1978) 18-hydroxycorticosterone: a review. J Steroid Biochem 9: 273–286

    Google Scholar 

  116. Ulick S, Nicolis GL, Vetter KK (1964) 18-OH-corticosterone to aldosterone. In: Boulien EG, Rober P (eds) Aldosterone. Blackwell, Oxford

    Google Scholar 

  117. Neher R (1979) Aldosterone: chemical aspects and related enzymology. J Endocrinol 81: 25–35

    Google Scholar 

  118. Cushmann DW, Cheung HS, Sabo EF, Ondetti MA (1977) Design of potent competitive inhibitors of angiotensin-converting enzyme, carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16: 5484–5490

    Google Scholar 

  119. Dollery CT, Miyamori I (1980) Indomethacin and the hypotensive action of captopril in DOCA salt hypertensive rats. Br J Pharmacol 68: 117p - 118 p

    PubMed  CAS  Google Scholar 

  120. Erdös EG (1976) Conversion of angiotensin Ito angiotensin II. Am J Med 60: 749–759

    PubMed  Google Scholar 

  121. Furgeson RK, Turini GA, Brunner HR, Gavras H (1977) A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet 1: 775–778

    Google Scholar 

  122. Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich RA, McKinstry DN (1978) Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med 298: 991–995

    PubMed  CAS  Google Scholar 

  123. Johnston CI, McGrath BP, Millar JA, Matthews PG (1979) Long-term effects of captopril (SQ 14225) on blood pressure and hormone levels in essential hypertension. Lancet 2: 493–496

    PubMed  CAS  Google Scholar 

  124. Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin converting enzyme: new class of orally-active antihypertensive agents. Science 196: 441–444

    PubMed  CAS  Google Scholar 

  125. Overlack A, Stumpe KO, Kühnert M, Kolloch R, Ressel C, Heck I, Krück F (1981) Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition. Klin Wochenschr 59: 69–74

    PubMed  CAS  Google Scholar 

  126. Swales JD (1979) Arterial wall or plasma renin in hypertension? Clin Sci 56: 293–298

    PubMed  CAS  Google Scholar 

  127. Thurston H, Swales JD, Bing RF, Hurst BC, Marks ES (1980) Vascular renin-like activity and blood pressure maintenance in the rat. Studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension 6: 643–649

    Google Scholar 

  128. Abe K, Sakurai Y, Irokawa N, Miyazaki S, Yasujima M, Chiba S, Saito K, Otsuka Y, Yoshinaga S (1977) Studies on urinary kallikrein and kinin in essential hypertension. In: Haberland GL, Rohen JW, Suzuki T (eds) Kininogenases 4. Schattauer, Stuttgart New York, p 351

    Google Scholar 

  129. Carretero OA, Scicli AG (1980) The renal kallikrein-kinin system. Am J Physiol 238: F247

    PubMed  CAS  Google Scholar 

  130. Danforth E, Moore RO (1959) Intestinal absorption of insulin in the rat. Endocrinology 65: 118–121

    PubMed  CAS  Google Scholar 

  131. Fritz H, Brey B, Schmal A, Werle E (1969) Zur Identität des Progressiv-Antikallikreins mit al -Antitrypsin aus Humanserum. Hoppe Seylers Z Physiol Chem 350: 1551–1559

    PubMed  CAS  Google Scholar 

  132. Geiger R, Stuckstedte U, Fritz H (1980) Isolation and characterization of human urinary kallikrein. Hoppe Seylers Z Physiol Chem 361: 1003–1009

    PubMed  CAS  Google Scholar 

  133. Goetze H, Rothman SS (1975) Enteropancreatic circulation of digestive enzyme as a conservation mechanism. Nature 257: 607

    CAS  Google Scholar 

  134. Lechi A, Covi G, Lechi C, Corgnati A, Arosio E, Zatti M, Scuro IA (1978) Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism. Clin Sci Mol Med 55: 51–55

    PubMed  CAS  Google Scholar 

  135. Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 60: 129–138

    Google Scholar 

  136. Margolius HS, Geller R, Pisano JJ, Sjoerdsma A (1971) Altered urinary kallikrein excretion in human hypertension. Lancet 2: 1063–1065

    Google Scholar 

  137. Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1974) Urinary kallikrein excretion in hypertensive man. Relationship to sodium intake and sodium-retaining steroids. Circ Res 35: 820–825

    Google Scholar 

  138. McGiff JC, Nasjletti A (1976) Kinins, renal function and blood pressure regulation. Fed Proc 35: 172–174

    PubMed  CAS  Google Scholar 

  139. Moriwaki C, Moriya H, Yamaguchi K, Kizuki K, Fujimori H (1972) Intestinal absorption of pancreatic kallikrein and some aspects of its physiological role. In: Haberland GL, Rohen JW (eds) Kininogenases. Kallikrein. Schattauer, Stuttgart New York, p 57

    Google Scholar 

  140. Nangu T (1977) Studies on clinical effects of kallikrein preparations with the photoelectric finger-plethysmography. In: Haberland GL, Rohen JW, Suzuki T (eds) Kininogenases 4. Schattauer, Stuttgart New York, p 333

    Google Scholar 

  141. Nustad K, Vaaje K (1975) Synthesis of kallikreins by rat kidney slices. Br J Pharmacol 53: 229–234

    PubMed  CAS  Google Scholar 

  142. Overlack A, Stumpe KO, Ressel C, Kolloch R, Zywzok W, Krück F (1980) Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension. Klin Wochenschr 58: 37–42

    PubMed  CAS  Google Scholar 

  143. Schill WB (1976) Die Behandlung männlicher Fertilitätsstörungen mit Kallikrein. Dtsch Med Wochenschr 101: 1773–1778

    PubMed  CAS  Google Scholar 

  144. Wicklmayr M, Dietze G (1977) Effect of oral kallikrein and intrabrachial-arterial bradykinin of forearm-metabolism in matury onset diabetes. In: Haberland GL, Rohen JW, Suzuki T (eds) Kininogenases 4. Schattauer, Stuttgart New York, p 299

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

K. Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Franz, IW. et al. (1981). Hypertonie. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 87. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47092-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-47092-9_10

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0327-6

  • Online ISBN: 978-3-642-47092-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics